ArticleCancer medicine2025

Healthcare Resource Utilization and Costs in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia Treated With Covalent Bruton's Tyrosine Kinase Inhibitors: Real-World Impact of Cardiovascular Adverse Events.

Mavis Obeng-Kusi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.